Prognostic role of demographic indicators and Charlson comorbidity index in oxygen-dependent patients with coronavirus disease (COVID-19)
DOI:
https://doi.org/10.14739/2310-1237.2022.3.266544Keywords:
coronavirus disease COVID-19, viral infection, comorbidity, risk factors, prognosisAbstract
Aim. The aim of our work is to establish the prognostic significance of demographic indicators and the Charlson comorbidity index (CCI) in oxygen-dependent patients with coronavirus disease (COVID-19).
Material and methods. The research included 211 oxygen-dependent patients with COVID-19: I group – 94 patients who recovered; II group – 117 patients, the disease ended fatally. We used the WHO age classification when analyzing the age structure of patients. The Charlson comorbidity index was calculated for each patient. The patients were divided into groups Statistical data processing was carried out in the program Statistica for Windows 13 (StatSoft Inc., No. JPZ804I382130ARCN10-J).
Results. It was established that the median age of the ІІ group patients was higher (P < 0.001) than patients the I in group. Elderly patients were more often registered in the ІІ group than among patients in group I (25.6 % vs. 8.5 %, P = 0.001). Middle-aged patients were more often registered in the І group than among patients in the II group (34.0 % vs. 19.4 %, P = 0.02). According to the result of the ROC analysis, the prognostic value of the age of the patients was established, namely, under conditions of age >66 years (AUC = 0.636, Р = 0.002), the probability of a fatal outcome of COVID-19 was significant.
Analysis of the influence of comorbid conditions on the risk of COVID-19 fatal outcome in oxygen-dependent patients according to the CCI showed that the absence of comorbid pathology was more common among patients of group I than among patients of group II (12.8 % vs. 2.6 %, P = 0.004). The level of CCI in patients of the II group significantly exceeded the corresponding indicator of the patients of the I group (P < 0.01), who recovered. According to the obtained result of the ROC analysis, the prognostic value of this indicator was established, namely under the conditions of the CCI index >5 in oxygen-dependent patients with COVID-19 (AUC = 0.652, P < 0.001) the probability of fatal outcome of the disease was significant.
Conclusions. In oxygen-dependent patients with COVID-19, patient age and comorbidity are associated with disease outcome. Under conditions of age >66 years (AUC = 0.636, P = 0.002) and the Charlson comorbidity index >5, the probability of a fatal outcome of the disease is significant (AUC = 0.652, P < 0.001).
References
Borges do Nascimento, I. J., Cacic, N., Abdulazeem, H. M., von Groote, T. C., Jayarajah, U., Weerasekara, I., Esfahani, M. A., Civile, V. T., Marusic, A., Jeroncic, A., Carvas Junior, N., Pericic, T. P., Zakarija-Grkovic, I., Meirelles Guimarães, S. M., Luigi Bragazzi, N., Bjorklund, M., Sofi-Mahmudi, A., Altujjar, M., Tian, M., Arcani, D. M. C., … Marcolino, M. S. (2020). Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis. Journal of clinical medicine, 9(4), 941. https://doi.org/10.3390/jcm9040941
Onder, G., Rezza, G., & Brusaferro, S. (2020). Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA, 323(18), 1775-1776. https://doi.org/10.1001/jama.2020.4683
Madjid, M., Safavi-Naeini, P., Solomon, S. D., & Vardeny, O. (2020). Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA cardiology, 5(7), 831-840. https://doi.org/10.1001/jamacardio.2020.1286
Ortiz-Prado, E., Simbaña-Rivera, K., Gómez-Barreno, L., Rubio-Neira, M., Guaman, L. P., Kyriakidis, N. C., Muslin, C., Jaramillo, A. M. G., Barba-Ostria, C., Cevallos-Robalino, D., Sanches-SanMiguel, H., Unigarro, L., Zalakeviciute, R., Gadian, N., & López-Cortés, A. (2020). Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagnostic microbiology and infectious disease, 98(1), 115094. https://doi.org/10.1016/j.diagmicrobio.2020.115094
CDC COVID-19 Response Team (2020). Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR. Morbidity and mortality weekly report, 69(12), 343-346. https://doi.org/10.15585/mmwr.mm6912e2
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020). The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020. China CDC weekly, 2(8), 113-122. https://doi.org/10.46234/ccdcw2020.032
Bwire G. M. (2020). Coronavirus: Why Men are More Vulnerable to Covid-19 Than Women?. SN comprehensive clinical medicine, 2(7), 874-876. https://doi.org/10.1007/s42399-020-00341-w
Alharthy, A., Aletreby, W., Faqihi, F., Balhamar, A., Alaklobi, F., Alanezi, K., Jaganathan, P., Tamim, H., Alqahtani, S. A., Karakitsos, D., & Memish, Z. A. (2021). Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study. Journal of epidemiology and global health, 11(1), 98-104. https://doi.org/10.2991/jegh.k.200928.001
Ashraf, O., Virani, A., & Cheema, T. (2021). COVID-19: An Update on the Epidemiological, Clinical, Preventive, and Therapeutic Management of 2019 Novel Coronavirus Disease. Critical care nursing quarterly, 44(1), 128-137. https://doi.org/10.1097/CNQ.0000000000000346
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., Zhang, Y., Song, J., Wang, S., Chao, Y., Yang, Z., Xu, J., Zhou, X., Chen, D., Xiong, W., Xu, L., … Song, Y. (2020). Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA internal medicine, 180(7), 934-943. https://doi.org/10.1001/jamainternmed.2020.0994
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., Cohen, S. L., Cookingham, J., Coppa, K., Diefenbach, M. A., Dominello, A. J., Duer-Hefele, J., Falzon, L., Gitlin, J., Hajizadeh, N., Harvin, T. G., … Zanos, T. P. (2020). Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA, 323(20), 2052-2059. https://doi.org/10.1001/jama.2020.6775
Ssentongo, P., Ssentongo, A. E., Heilbrunn, E. S., Ba, D. M., & Chinchilli, V. M. (2020). Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PLoS ONE. Public Library of Science. https://doi.org/10.1371/journal.pone.0238215
Ng, W. H., Tipih, T., Makoah, N. A., Vermeulen, J. G., Goedhals, D., Sempa, J. B., Burt, F. J., Taylor, A., & Mahalingam, S. (2021). Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis. mBio, 12(1), e03647-20. https://doi.org/10.1128/mBio.03647-20
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of chronic diseases, 40(5), 373-383. https://doi.org/10.1016/0021-9681(87)90171-8
Garibaldi, B. T., Wang, K., Robinson, M. L., Zeger, S. L., Bandeen-Roche, K., Wang, M. C., Alexander, G. C., Gupta, A., Bollinger, R., & Xu, Y. (2021). Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19. JAMA network open, 4(3), e213071. https://doi.org/10.1001/jamanetworkopen.2021.3071
Al-Baadani, A., Eltayeb, N., Alsufyani, E., Albahrani, S., Basheri, S., Albayat, H., Batubara, E., Ballool, S., Al Assiri, A., Faqihi, F., Musa, A. B., Robert, A. A., Alsherbeeni, N., & Elzein, F. (2021). Efficacy of tocilizumab in patients with severe COVID-19: Survival and clinical outcomes. Journal of infection and public health, 14(8), 1021-1027. https://doi.org/10.1016/j.jiph.2021.05.015
Liu, K., Chen, Y., Lin, R., & Han, K. (2020). Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. The Journal of infection, 80(6), e14-e18. https://doi.org/10.1016/j.jinf.2020.03.005
Kaur, R., Singh, S., Singh, T. G., Sood, P., & Robert, J. (2022). Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination. Inflammopharmacology, 30(1), 1-21. https://doi.org/10.1007/s10787-021-00904-w
Saheb Sharif-Askari, N., Saheb Sharif-Askari, F., Alabed, M., Temsah, M. H., Al Heialy, S., Hamid, Q., & Halwani, R. (2020). Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD. Molecular therapy. Methods & clinical development, 18, 1-6. https://doi.org/10.1016/j.omtm.2020.05.013
Schuler, B. A., Habermann, A. C., Plosa, E. J., Taylor, C. J., Jetter, C., Negretti, N. M., Kapp, M. E., Benjamin, J. T., Gulleman, P., Nichols, D. S., Braunstein, L. Z., Hackett, A., Koval, M., Guttentag, S. H., Blackwell, T. S., Webber, S. A., Banovich, N. E., Vanderbilt COVID-19 Consortium Cohort, Human Cell Atlas Biological Network, Kropski, J. A., … Sucre, J. M. (2021). Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium. The Journal of clinical investigation, 131(1), e140766. https://doi.org/10.1172/JCI140766
Lynch, S. M., Guo, G., Gibson, D. S., Bjourson, A. J., & Rai, T. S. (2021). Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease. Cells, 10(12), 3367. https://doi.org/10.3390/cells10123367
Bajaj, V., Gadi, N., Spihlman, A. P., Wu, S. C., Choi, C. H., & Moulton, V. R. (2021). Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?. Frontiers in physiology, 11, 571416. https://doi.org/10.3389/fphys.2020.571416
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., Zhang, X., Zhang, M., Wu, S., Song, J., Chen, T., Han, M., Li, S., Luo, X., Zhao, J., & Ning, Q. (2020). Clinical and immunological features of severe and moderate coronavirus disease 2019. The Journal of clinical investigation, 130(5), 2620-2629. https://doi.org/10.1172/JCI137244
Rydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., Kato, Y., Crotty, E. G., Kim, C., Rawlings, S. A., Mateus, J., Tse, L. P. V., Frazier, A., Baric, R., Peters, B., Greenbaum, J., … Crotty, S. (2020). Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity. Cell, 183(4), 996-1012.e19. https://doi.org/10.1016/j.cell.2020.09.038
Foresta, C., Rocca, M. S., & Di Nisio, A. (2021). Gender susceptibility to COVID-19: a review of the putative role of sex hormones and X chromosome. Journal of endocrinological investigation, 44(5), 951-956. https://doi.org/10.1007/s40618-020-01383-6
Li, B., Yang, J., Zhao, F., Zhi, L., Wang, X., Liu, L., Bi, Z., & Zhao, Y. (2020). Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clinical research in cardiology, 109(5), 531-538. https://doi.org/10.1007/s00392-020-01626-9
Riabokon, O. V., Tumanska, L. M., Cherkaskyi, V. V., & Riabokon, Yu. Yu. (2021). Clinical and pathomorphological analysis of deaths from COVID-19 in 2020. Pathologia, 18(3), 269-277. https://doi.org/10.14739/2310-1237.2021.3.242247
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
